DexFactory  Finance - dapp.expert
DexFactory
Category: Finance Blockchain: BNB Chain Language: English Platform: Web
Contact person’s name: https://t.me/dexfactory Email: Location: Sweden

DexFactory

Trade Smarter,Not harder.

Our Decentralized Trading ROI Platform Makes It Possible. Daily Earn Up To 2% to 5% On Your Investment

Our platform operates by having investors invest in it. Once invested, they can earn a daily ROI of up to 2-5% on their investments. They can choose to reinvest their earnings daily, and collect their earnings after a period of time. After collection, they can withdraw their earnings within 24 hours. All the investments in the total value locked (TVL) are securely traded on decentralized exchanges, generating income to sustain and extend the lifespan of the TVL.

Is there any future of DexFactory?

DexFactory has a very bright future because it is an innovative idea that facilitates decentralized trades, ultimately increasing the total value locked (TVL). Additionally, we plan to launch our token in September, following the success of DexFactory.

Can you explain how the rewards and withdrawals work?

If you invest 1 Binance Coin (BNB) as a new user on our platform, you will receive a 2% return on investment (ROI) over a period of 1 to 15 days. This means that you will receive a daily reward of 0.02 BNB (calculated as 1/100 * 2 = 0.02 BNB).After every 24 hours, your rewards will be added to your investment, and the next 48 hours will bring an increased reward of 0.04 BNB. You have the option to either reinvest your rewards, which will further increase your investment, or collect your reward, which will be added to your withdraw amount. Once you collect your reward, you can withdraw the total amount available to you every 24 hours.

Dapp DexFactory

DexFactory Statistics

Users
24 hr: 0
0%
Total: 0
(2400 days)
ATH: 0
(Apr 19, 2024)
Volume
24 hr: 0
0%
Total: 0
(2400 days)
ATH: 0
(Apr 19, 2024)
Transactions
24 hr: 0
0%
Total: 0
(2400 days)
ATH: 0
(Apr 19, 2024)
0

Reaction to the article

Reviews (0)